PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors. Here, MTOR is linked to digestive system neuroendocrine tumor, grade 1/2.